Fig. 4.
Fig. 4. Immunoprecipitation of thrombin-activated C2 domain chimeras by IgG fraction from patient RS. Recombinant factor V constructs metabolically labeled with [35S]methionine included rHFV des B, chimera 1A, chimera 2A, chimera 3A, chimera 7A, and chimera 5A. Samples were first incubated with 2 nmol/L thrombin for 1 minute at 37°C and then immunoprecipitated with either the polyclonal rabbit anti-human factor V antibody or the IgG fraction from patient RS, as shown. The immunoprecipitates were analyzed by 6% SDS-PAGE and visualized by autoradiography. A nonspecific, high-molecular-weight band (>200 kD) is seen in all the immunoprecipitations of conditioned media, including the control IgG fraction from pooled normal plasma. Molecular-weight standards are shown on the left, and the positions of the factor Va heavy chain and light chain on the right.

Immunoprecipitation of thrombin-activated C2 domain chimeras by IgG fraction from patient RS. Recombinant factor V constructs metabolically labeled with [35S]methionine included rHFV des B, chimera 1A, chimera 2A, chimera 3A, chimera 7A, and chimera 5A. Samples were first incubated with 2 nmol/L thrombin for 1 minute at 37°C and then immunoprecipitated with either the polyclonal rabbit anti-human factor V antibody or the IgG fraction from patient RS, as shown. The immunoprecipitates were analyzed by 6% SDS-PAGE and visualized by autoradiography. A nonspecific, high-molecular-weight band (>200 kD) is seen in all the immunoprecipitations of conditioned media, including the control IgG fraction from pooled normal plasma. Molecular-weight standards are shown on the left, and the positions of the factor Va heavy chain and light chain on the right.

Close Modal

or Create an Account

Close Modal
Close Modal